Sulfadicramide

{{Short description|Chemical compound}}

{{cs1 config|name-list-style=vanc|display-authors=6}}

{{Infobox drug

| drug_name =

| INN =

| type =

| image = Sulfadicramide.png

| width =

| alt =

| caption =

| image2 =

| width2 =

| alt2 =

| caption2 =

| imageL =

| widthL =

| altL =

| imageR =

| widthR =

| altR =

| captionLR =

| pronounce =

| tradename =

| Drugs.com =

| MedlinePlus =

| licence_CA =

| licence_EU =

| DailyMedID =

| licence_US =

| pregnancy_AU =

| pregnancy_AU_comment =

| pregnancy_category=

| dependency_liability =

| addiction_liability =

| routes_of_administration =

| class =

| ATCvet =

| ATC_prefix = S01

| ATC_suffix = AB03

| ATC_supplemental =

| legal_AU =

| legal_AU_comment =

| legal_BR =

| legal_BR_comment =

| legal_CA =

| legal_CA_comment =

| legal_DE =

| legal_DE_comment =

| legal_NZ =

| legal_NZ_comment =

| legal_UK =

| legal_UK_comment =

| legal_US =

| legal_US_comment =

| legal_EU =

| legal_EU_comment =

| legal_UN =

| legal_UN_comment =

| legal_status =

| bioavailability =

| protein_bound =

| metabolism =

| metabolites =

| onset =

| elimination_half-life =

| duration_of_action=

| excretion =

| CAS_number = 115-68-4

| CAS_supplemental =

| PubChem = 8281

| PubChemSubstance =

| IUPHAR_ligand =

| DrugBank = DB13214

| ChemSpiderID =

| UNII = 7WZ5EG263C

| KEGG = D07412

| ChEBI = 135039

| ChEMBL = 2104910

| NIAID_ChemDB =

| PDB_ligand =

| synonyms =

| IUPAC_name = N-(4-aminophenyl)sulfonyl-3-methylbut-2-enamide

| C=11 | H=14 | N=2 | O=3 | S=1

| molecular_weight =

| SMILES = CC(=CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N)C

| Jmol =

| StdInChI = InChI=1S/C11H14N2O3S/c1-8(2)7-11(14)13-17(15,16)10-5-3-9(12)4-6-10/h3-7H,12H2,1-2H3,(H,13,14)

| StdInChI_comment =

| StdInChIKey = XRVJPLDTMUSSDE-UHFFFAOYSA-N

| density =

| density_notes =

| melting_point =

| melting_high =

| melting_notes =

| boiling_point =

| boiling_notes =

| solubility =

| sol_units =

| specific_rotation =

}}

Sulfadicramide (marketed as Irgamid) is an anti-infective.{{cite journal | vauthors = Grześkowiak E, Partyka D, Simon M, Zgrabczyńska M, Wiśniewska A | title = Technology and physico-chemical evaluation of solid ocular inserts containing sulfadicramide and hyaluronic acid | journal = Acta Poloniae Pharmaceutica | volume = 58 | issue = 6 | pages = 453–458 | year = 2001 | pmid = 12197618 }}